PriceTargets.com logo

23448 (LAB.TO) - LAB Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.00 As of 01/1/2000 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for LAB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New 23448 (LAB.TO) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LAB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LAB

Analyst Price Target is C$0.00
This price target is based on 0 analysts offering 12 month price targets for 23448 (LAB.TO) in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a NaN upside from the last price of C$0.00.

This chart shows the closing price for LAB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in 23448 (LAB.TO). This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/3/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/2/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/31/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/26/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/15/2022Roth CapitalDowngradeBuy ➝ Neutral
6/30/2022Noble FinancialInitiated CoverageBuyC$0.60
11/2/2020Alliance Global PartnersReiterated RatingBuy
6/18/2020AltaCorp CapitalDowngradeOutperform ➝ Sector Perform
6/15/2020Pi FinancialReiterated RatingBuy ➝ Buy
2/10/2020Roth CapitalReiterated RatingBuy
(Data available from 4/26/2019 forward)

News Sentiment Rating

0.10 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
9/29/2023
  • 1 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
10/29/2023
  • 0 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
11/28/2023
  • 1 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
12/28/2023
  • 0 very positive mentions
  • 4 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
Mentions as of
1/27/2024
  • 1 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
2/26/2024
  • 0 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
3/27/2024
  • 2 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
4/26/2024

Current Sentiment

  • 2 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

23448 (LAB.TO) logo
Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Its customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, the Company strives to increase the quality of life for all.
Read More

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of 23448 (LAB.TO)?

The following Wall Street research analysts have issued research reports on 23448 (LAB.TO) in the last twelve months:
View the latest analyst ratings for LAB.

What is the current price target for 23448 (LAB.TO)?

0 Wall Street analysts have set twelve-month price targets for 23448 (LAB.TO) in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for 23448 (LAB.TO) in the next year.
View the latest price targets for LAB.

What is the current consensus analyst rating for 23448 (LAB.TO)?

23448 (LAB.TO) currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for LAB.

What other companies compete with 23448 (LAB.TO)?

Other companies that are similar to 23448 (LAB.TO) include (EDW.V), (FSN.V), (FTE.V), 108946 (AUA.V) and 111040 (DNI.V). Learn More about companies similar to 23448 (LAB.TO).

How do I contact 23448 (LAB.TO)'s investor relations team?

23448 (LAB.TO)'s physical mailing address is 7000 Shoreline Ct Ste 100, South San Francisco, California 94080-7603. The company's listed phone number is 16502666000. The official website for 23448 (LAB.TO) is www.fluidigm.com. Learn More about contacing 23448 (LAB.TO) investor relations.